FMO3 and atherosclerosis: Previous studies have confirmed that FMO3 knockout can significantly reduce gut-microbiota-dependent TMAO-induced atherosclerosis and thrombosis, suggesting that therapies targeting FMO3 may reduce the ischemic stroke risk [60,177,178].